The big news is that the world's largest pharmaceutical companywill spend upwards of $400 million over the next five years toexpand Pfizer Consumer Healthcare's world headquarters campus here,which it inherited a few years ago when it acquired Warner-Lambert.Pfizer officials are already talking to local officials about aproject that would add 900,000 sf to the existing 1.3 million sf onthe 175-acre site, boosting its capacity from 3,700 to 5,000employees.

"We have built a great relationship with the community andexpansion of our operations here will enable us to meet our futuregrowth need with minimal disruption," says Marc Robinson, presidentof Pfizer Consumer Healthcare in a statement. "The Morris Plainssite allows our R&D and business teams to operate seamlessly inone location."

"New Jersey is critical to our future success," says Pfizerchairman/CEO Hank McKinnell, also in a statement. "The investmentwe are announcing today reaffirms our commitment to New Jersey andto the strong partnerships we have established here."

Want to continue reading?
Become a Free ALM Digital Reader.

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.